Vimarsana
Biggest News Aggregation in the World

Ageing Res News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ageing Res. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ageing Res Today - Breaking & Trending Today

Can Semaglutide Help in Psychiatry Too? Research Shows Promise for AD and PD - Vimarsana News

Can Semaglutide Help in Psychiatry Too? Research Shows Promise for AD and PD

Available evidence from preclinical studies indicates that semaglutide shows promise for treating Alzheimer disease and Parkinson disease.

Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Alzheimer's Dementia | Illinois - Vimarsana News

Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Alzheimer's Dementia | Illinois

PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Apr 16, 2023--

Source: wsiltv.com
Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Me - Vimarsana News

Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Me

The Prescription Drug User Fee Act (PDUFA) target action date is May 10, 2023PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc., (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the Joint Meeting of the Psychopharmacologic Drugs Advisory C...

ANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in Long-Term 48-Week Phase 2 Extension Study in Patients with Parkinson's Disease Dementia - Vimarsana News

ANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in Long-Term 48-Week Phase 2 Extension Study in Patients with Parkinson's Disease Dementia

Study successfully achieved both primary and secondary objectives ANAVEX®2-73 treatment resulted in improvements of all efficacy endpoints over 48 Weeks Anavex plans to proceed to... | March 30, 2023

5 Ways to Prevent and Reverse Age-Related Muscle Loss - Vimarsana News

5 Ways to Prevent and Reverse Age-Related Muscle Loss

Omega-3 fats, whey and exercise are just some meaningful ways to fight sarcopenia, or age-related muscle loss, before ...